CS
IBER.U

Clear Street’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Clear Street’s Portfolio IBER.U Stock Details IBER.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,839
Closed -$157K – 1427
2022
Q3 		$157K Buy
15,839
+15,529
+5,009% +$154K ﹤0.01% 160
2022
Q2 		$3K Buy
+310
New +$3.06K ﹤0.01% 830
2022
Q1 		– Sell
-41
Closed – – 586
2021
Q4 		$0 Buy
+41
New +$409 ﹤0.01% 288

Other funds holding IBER.U

SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street's IBER.U Position: Q4 2022 in Review

Clear Street sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q4 2022, closing a stake of 15,839 shares — an estimated $157K sold.

Clear Street first reported a position in IBER.U in Q4 2021 and held it in 3 quarters. The position peaked at $157K in Q3 2022. 10 funds tracked by Wall St. Rank hold IBER.U as of Q4 2022.

  • Clear Street reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q4 2022 after selling out during the quarter.
  • Clear Street sold 15,839 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q4 2022, an estimated $157K.
  • Clear Street first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q4 2021 and held it in 3 quarters.
  • Clear Street's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $157K in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q4 2022.

Based on Clear Street's 13F filing for Q4 2022, filed 13 Feb 2023.